I lighed med andre sulfonylurinstoffer skyldes denne virkning en øget følsomhed for den fysiologiske glukosestimulation i pankreas β- celler.
As with other sulphonylureas, this effect is based on an improvement in responsiveness of pancreatic beta cells to the physiological glucose stimulus.